DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Adingupu DD, Göpel SO, Grönros J. et al.
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice.
Cardiovasc Diabetol 2019;
18 (01) 16
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.